Patrick O'Brien, General Counsel at ARROWHEAD PHARMACEUTICALS, INC. (ARWR), sold 180,000 shares at $86.72 ($15.9M) on 2021-02-08, disclosed to the SEC on 2021-02-10.
Open-market sale of $15.9M ARWR by General Counsel. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $86.72 | 7,961 | $690K | 4.3% |
| 2 | $86.72 | 7,961 | $690K | 4.3% |
| 3 | $88.08 | 31,255 | $2.8M | 17.3% |
| 4 | $88.08 | 31,255 | $2.8M | 17.3% |
| 5 | $88.88 | 45,348 | $4.0M | 25.3% |
| 6 | $88.88 | 45,348 |
| $4.0M |
| 25.3% |
| 7 | $89.66 | 5,436 | $487K | 3.1% |
| 8 | $89.66 | 5,436 | $487K | 3.1% |
| Total | $88.46 avg | 180,000 | $15.9M | 100% |
| Filing → |
| GLRE | SELL | 2025-05-14 | $267K | — | Filing → |
| ARWR | SELL | 2025-01-07 | $1.3M | — | Filing → |
| ARWR | SELL | 2024-01-05 | $1.9M | — | Filing → |